222 related articles for article (PubMed ID: 34118772)
1. Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery.
Moreira A; Poulet A; Masliah-Planchon J; Lecerf C; Vacher S; Larbi Chérif L; Dupain C; Marret G; Girard E; Syx L; Hoffmann C; Jeannot E; Klijanienko J; Guillou I; Mariani O; Dubray-Vautrin A; Badois N; Lesnik M; Choussy O; Calugaru V; Borcoman E; Baulande S; Legoix P; Albaud B; Servant N; Bieche I; Le Tourneau C; Kamal M
ESMO Open; 2021 Aug; 6(4):100178. PubMed ID: 34118772
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
[TBL] [Abstract][Full Text] [Related]
3. Interference of tumour mutational burden with outcome of patients with head and neck cancer treated with definitive chemoradiation: a multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group.
Eder T; Hess AK; Konschak R; Stromberger C; Jöhrens K; Fleischer V; Hummel M; Balermpas P; von der Grün J; Linge A; Lohaus F; Krause M; Baumann M; Stuschke M; Zips D; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Budach V; Tinhofer I;
Eur J Cancer; 2019 Jul; 116():67-76. PubMed ID: 31173964
[TBL] [Abstract][Full Text] [Related]
4. Extranodal extension in resected oral cavity squamous cell carcinoma: more to it than meets the eye.
Agarwal JP; Kane S; Ghosh-Laskar S; Pilar A; Manik V; Oza N; Wagle P; Gupta T; Budrukkar A; Murthy V; Swain M
Laryngoscope; 2019 May; 129(5):1130-1136. PubMed ID: 30421434
[TBL] [Abstract][Full Text] [Related]
5. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
[TBL] [Abstract][Full Text] [Related]
6. The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma.
Wilson HL; D'Agostino RB; Meegalla N; Petro R; Commander S; Topaloglu U; Zhang W; Porosnicu M
Oncologist; 2021 Feb; 26(2):e279-e289. PubMed ID: 33098199
[TBL] [Abstract][Full Text] [Related]
7. Comparing Genomic Landscapes of Oral and Cutaneous Squamous Cell Carcinoma of the Head and Neck: Quest for Novel Diagnostic Markers.
Gupta R; Strbenac D; Satgunaseelan L; Cheung VK; Narayanappa H; Ashford B; Mitchell J; Thind A; Palme CE; Ch'ng S; Low TH; Wykes J; Willet CE; Chew T; Yang J; Ranson M; Clark JR
Mod Pathol; 2023 Aug; 36(8):100190. PubMed ID: 37080394
[TBL] [Abstract][Full Text] [Related]
8. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
9. A prognostic model for oral squamous cell carcinoma using 7 genes related to tumor mutational burden.
Wu F; Du Y; Hou X; Cheng W
BMC Oral Health; 2022 Apr; 22(1):152. PubMed ID: 35488327
[TBL] [Abstract][Full Text] [Related]
10. Plasma cell-free DNA methylome profiling in pre- and post-surgery oral cavity squamous cell carcinoma.
Patel KB; Padhya TA; Huang J; Hernandez-Prera JC; Li T; Chung CH; Wang L; Wang X
Mol Carcinog; 2023 Apr; 62(4):493-502. PubMed ID: 36636912
[TBL] [Abstract][Full Text] [Related]
11. Whole-exome sequencing identifies biosignatures that predict adverse survival outcomes in surgically treated patients with oral cavity squamous cell carcinoma.
Liao CT; Yang LY; Lee LY; Lin CY; Wang HM; Ng SH; Yen TC; Fan WL; Hsieh JC
Oral Oncol; 2021 Nov; 122():105547. PubMed ID: 34700279
[TBL] [Abstract][Full Text] [Related]
12. TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas.
Saito Y; Kage H; Kobayashi K; Yoshida M; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Head Neck; 2023 Dec; 45(12):3107-3118. PubMed ID: 37815002
[TBL] [Abstract][Full Text] [Related]
13. TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapy.
Sambasivan K; Sassoon I; Thavaraj S; Kennedy R; Doss G; Michaelidou A; Odell E; Sandison A; Hall G; Morgan P; Collins LHC; Lyons A; Cascarini L; Fry A; Oakley R; Simo R; Jeannon JP; Petkar I; Reis Ferreira M; Kong A; Lei M; Guerrero Urbano T
Radiother Oncol; 2021 Jul; 160():54-60. PubMed ID: 33845044
[TBL] [Abstract][Full Text] [Related]
14. Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer--Comparison with pathological risk factors according to the NCCN guidelines.
Lee LY; Lin CY; Cheng NM; Tsai CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Kang CJ; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
Cancer Med; 2021 Oct; 10(19):6627-6641. PubMed ID: 34533269
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Implications of Skin Invasion in Locally Advanced Oral Cavity Squamous Cell Carcinoma.
Diebolt JH; Yu KM; Wood S; Ziegler A; France A; Villwock MR; Alvi SA; Kakarala K; Shnayder Y; Gan GN; Lominska CE; Neupane P; Bur AM
Otolaryngol Head Neck Surg; 2023 Jul; 169(1):69-75. PubMed ID: 35917167
[TBL] [Abstract][Full Text] [Related]
16. Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation.
Tinhofer I; Stenzinger A; Eder T; Konschak R; Niehr F; Endris V; Distel L; Hautmann MG; Mandic R; Stromberger C; Weichert W; Budach V
Ann Oncol; 2016 Dec; 27(12):2262-2268. PubMed ID: 27681865
[TBL] [Abstract][Full Text] [Related]
17. [Application value of whole exon sequencing and immune related indicators in the precision treatment of oral squamous cell carcinoma].
Xie S; Cai ZG; Shan XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):697-701. PubMed ID: 37534654
[TBL] [Abstract][Full Text] [Related]
18. Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity.
Laskar SG; Chaukar D; Deshpande M; Chatterjee A; Sinha S; Chakraborty S; Agarwal JP; Gupta T; Budrukkar A; Murthy V; Pai P; Chaturvedi P; Pantvaidya G; Deshmukh A; Nair D; Nair S; Prabhash K; Swain M; Kumar A; Noronha V; Patil V; Joshi A; DCruz A
Eur J Cancer; 2023 Mar; 181():179-187. PubMed ID: 36669426
[TBL] [Abstract][Full Text] [Related]
19. Impact of histological tumor grade on the behavior and prognosis of squamous cell carcinoma of the oral cavity.
Cariati P; Martinez Sahuquillo Rico A; Ferrari L; Pampin Ozan D; Gonzalez Corcóles C; Arroyo Rodriguez S; Ferrari S; Lara IM
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e808-e813. PubMed ID: 35811024
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of preoperative Geriatric Nutritional Risk Index in oral squamous cell carcinoma.
Ito Y; Abe A; Hayashi H; Momokita M; Furuta H
Oral Dis; 2023 Jul; 29(5):2076-2085. PubMed ID: 35582815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
